Trial Profile
A phase 3 trial of CRLX101 in combination with Avastin in patients with 3rd and 4th line Renal cell carcinoma
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 10 Aug 2015
Price :
$35
*
At a glance
- Drugs Camptothecin (Primary) ; Bevacizumab
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 10 Aug 2015 New trial record